Bicara Therapeutics Inc. (BCAX)

Bicara Therapeutics Statistics

Total Valuation

BCAX has a market cap or net worth of $1.43 billion. The enterprise value is $1.01 billion.

Market Cap	1.43B
Enterprise Value	1.01B

Important Dates

The next estimated earnings date is Tuesday, May 12, 2026, before market open.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

BCAX has 65.47 million shares outstanding. The number of shares has increased by 225.35% in one year.

Current Share Class	65.47M
Shares Outstanding	65.47M
Shares Change (YoY)	+225.35%
Shares Change (QoQ)	+1.06%
Owned by Insiders (%)	1.92%
Owned by Institutions (%)	63.46%
Float	42.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.93
P/TBV Ratio	3.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.58, with a Debt / Equity ratio of 0.00.

Current Ratio	14.58
Quick Ratio	14.33
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -30.88% and return on invested capital (ROIC) is -21.71%.

Return on Equity (ROE)	-30.88%
Return on Assets (ROA)	-20.67%
Return on Invested Capital (ROIC)	-21.71%
Return on Capital Employed (ROCE)	-38.70%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BCAX has paid $217,000 in taxes.

Income Tax	217,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +133.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+133.73%
50-Day Moving Average	17.79
200-Day Moving Average	15.16
Relative Strength Index (RSI)	70.32
Average Volume (20 Days)	571,425

Short Selling Information

The latest short interest is 9.36 million, so 14.30% of the outstanding shares have been sold short.

Short Interest	9.36M
Short Previous Month	9.27M
Short % of Shares Out	14.30%
Short % of Float	22.12%
Short Ratio (days to cover)	14.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-155.60M
Pretax Income	-137.73M
Net Income	-137.95M
EBITDA	-155.50M
EBIT	-155.60M
Earnings Per Share (EPS)	-$2.52

Balance Sheet

The company has $414.80 million in cash and $1.71 million in debt, with a net cash position of $413.09 million or $6.31 per share.

Cash & Cash Equivalents	414.80M
Total Debt	1.71M
Net Cash	413.09M
Net Cash Per Share	$6.31
Equity (Book Value)	401.45M
Book Value Per Share	7.37
Working Capital	393.10M

Cash Flow

In the last 12 months, operating cash flow was -$106.83 million and capital expenditures -$280,000, giving a free cash flow of -$107.11 million.

Operating Cash Flow	-106.83M
Capital Expenditures	-280,000
Depreciation & Amortization	105,000
Net Borrowing	n/a
Free Cash Flow	-107.11M
FCF Per Share	-$1.64

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCAX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-225.35%
Shareholder Yield	-225.35%
Earnings Yield	-9.67%
FCF Yield	-7.51%

Analyst Forecast

The average price target for BCAX is $28.00, which is 27.91% higher than the current price. The consensus rating is "Buy".

Price Target	$28.00
Price Target Difference	27.91%
Analyst Consensus	Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-35.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1